Dec. 19, 2013
/PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced that
, President and Chief Executive Officer, will be presenting at the 32
Annual J.P. Morgan Healthcare Conference on
Monday, January 13, 2014
Interested parties may listen via live audio broadcast to the presentation over the internet at
. Users can click the "Webcast" icon to access this file.
Interested parties may also view the presentation slides on the Company's investor relations website –
. The slides (titled "Investor Presentation") will be available on the website at or before the time of the Company's presentation at the conference.
: Sigma-Aldrich, a leading Life Science and High Technology company focused on enhancing human health and safety, manufactures and distributes more than 200,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 38 countries, has more than 9,000 employees worldwide and had sales of
in 2012. For more information about Sigma-Aldrich, please visit its website at
SOURCE Sigma-Aldrich Corporation